Literature DB >> 34294868

Higher CPAP levels improve functional residual capacity at birth in preterm rabbits.

Arjan B Te Pas1, Stuart B Hooper2,3, Tessa Martherus4, Michelle K Croughan5, Kelly J Crossley2, Megan J Wallace2, Erin V McGillick2, Marta Thio6, Charles C Roehr7, James T Pearson8,9,10, Katie Lee5, Gary Ruben5, Marcus J Kitchen5.   

Abstract

BACKGROUND: Preterm infants are commonly supported with 4-8 cm H2O continuous positive airway pressures (CPAP), although higher CPAP levels may improve functional residual capacity (FRC).
METHODS: Preterm rabbits delivered at 29/32 days (~26-28 weeks human) gestation received 0, 5, 8, 12, 15 cm H2O of CPAP or variable CPAP of 15 to 5 or 15 to 8 cm H2O (decreasing ~2 cm H2O/min) for up to 10 min after birth.
RESULTS: FRC was lower in the 0 (6.8 (1.0-11.2) mL/kg) and 5 (10.1 (1.1-16.8) mL/kg) compared to the 15 (18.8 (10.9-22.4) mL/kg) cm H2O groups (p = 0.003). Fewer kittens achieved FRC > 15 mL/kg in the 0 (20%), compared to 8 (36%), 12 (60%) and 15 (73%) cm H2O groups (p = 0.008). While breathing rates were not different (p = 0.096), apnoea tended to occur more often with CPAP < 8 cm H2O (p = 0.185). CPAP belly and lung bulging rates were similar whereas pneumothoraces were rare. Lowering CPAP from 15 to 5, but not 15 to 8 cm H2O, decreased FRC and breathing rates.
CONCLUSION: In all, 15 cm H2O of CPAP improved lung aeration and reduced apnoea, but did not increase the risk of lung over-expansion, pneumothorax or CPAP belly immediately after birth. FRC and breathing rates were maintained when CPAP was decreased to 8 cm H2O. IMPACT: Although preterm infants are commonly supported with 4-8 cm H2O CPAP at birth, preclinical studies have shown that higher PEEP levels improve lung aeration. In this study, CPAP levels of 15 cm H2O improved lung aeration and reduced apnoea in preterm rabbit kittens immediately after birth. In all, 15 cm H2O CPAP did not increase the risk of lung over-expansion (indicated by bulging between the ribs), pneumothorax, or CPAP belly. These results can be used when designing future studies on CPAP strategies for preterm infants in the delivery room.
© 2021. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 34294868     DOI: 10.1038/s41390-021-01647-8

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.953


  43 in total

1.  Laryngeal response to nasal ventilation in nonsedated newborn lambs.

Authors:  François Moreau-Bussière; Nathalie Samson; Marie St-Hilaire; Philippe Reix; Joëlle Rouillard Lafond; Elise Nsegbe; Jean-Paul Praud
Journal:  J Appl Physiol (1985)       Date:  2007-03-01

2.  Effects of a sustained inflation in preterm infants at birth.

Authors:  Jeroen J van Vonderen; Stuart B Hooper; Helmut D Hummler; Enrico Lopriore; Arjan B te Pas
Journal:  J Pediatr       Date:  2014-07-16       Impact factor: 4.406

3.  Changes over time in delivery room management of extremely low birth weight infants in Italy.

Authors:  Daniele Trevisanuto; Irene Satariano; Nicoletta Doglioni; Giulio Criscoli; Francesco Cavallin; Camilla Gizzi; Claudio Martano; Fabrizio Ciralli; Flaminia Torielli; Paolo Ernesto Villani; Sandra Di Fabio; Lorenzo Quartulli; Luigi Giannini
Journal:  Resuscitation       Date:  2014-05-02       Impact factor: 5.262

4.  Upper airway resistances in fetal sheep: the influence of breathing activity.

Authors:  R Harding; A D Bocking; J N Sigger
Journal:  J Appl Physiol (1985)       Date:  1986-01

5.  Nasal CPAP or intubation at birth for very preterm infants.

Authors:  Colin J Morley; Peter G Davis; Lex W Doyle; Luc P Brion; Jean-Michel Hascoet; John B Carlin
Journal:  N Engl J Med       Date:  2008-02-14       Impact factor: 91.245

6.  Caffeine to improve breathing effort of preterm infants at birth: a randomized controlled trial.

Authors:  Janneke Dekker; Stuart B Hooper; Jeroen J van Vonderen; Ruben S G M Witlox; Enrico Lopriore; Arjan B Te Pas
Journal:  Pediatr Res       Date:  2017-05-17       Impact factor: 3.756

7.  Repetitive versus standard tactile stimulation of preterm infants at birth - A randomized controlled trial.

Authors:  Janneke Dekker; Stuart B Hooper; Tessa Martherus; Sophie J E Cramer; Nan van Geloven; Arjan B Te Pas
Journal:  Resuscitation       Date:  2018-03-23       Impact factor: 5.262

8.  Early CPAP versus surfactant in extremely preterm infants.

Authors:  Neil N Finer; Waldemar A Carlo; Michele C Walsh; Wade Rich; Marie G Gantz; Abbot R Laptook; Bradley A Yoder; Roger G Faix; Abhik Das; W Kenneth Poole; Edward F Donovan; Nancy S Newman; Namasivayam Ambalavanan; Ivan D Frantz; Susie Buchter; Pablo J Sánchez; Kathleen A Kennedy; Nirupama Laroia; Brenda B Poindexter; C Michael Cotten; Krisa P Van Meurs; Shahnaz Duara; Vivek Narendran; Beena G Sood; T Michael O'Shea; Edward F Bell; Vineet Bhandari; Kristi L Watterberg; Rosemary D Higgins
Journal:  N Engl J Med       Date:  2010-05-16       Impact factor: 91.245

9.  The Effect of Initial High vs. Low FiO2 on Breathing Effort in Preterm Infants at Birth: A Randomized Controlled Trial.

Authors:  Janneke Dekker; Tessa Martherus; Enrico Lopriore; Martin Giera; Erin V McGillick; Jeroen Hutten; Ruud W van Leuteren; Anton H van Kaam; Stuart B Hooper; Arjan B Te Pas
Journal:  Front Pediatr       Date:  2019-12-12       Impact factor: 3.418

10.  Laryngeal closure impedes non-invasive ventilation at birth.

Authors:  Jessica R Crawshaw; Marcus J Kitchen; Corinna Binder-Heschl; Marta Thio; Megan J Wallace; Lauren T Kerr; Charles C Roehr; Katie L Lee; Genevieve A Buckley; Peter G Davis; Andreas Flemmer; Arjan B Te Pas; Stuart B Hooper
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2017-10-20       Impact factor: 5.747

View more
  1 in total

1.  Feasibility and Effect of Physiological-Based CPAP in Preterm Infants at Birth.

Authors:  Tessa Martherus; Kristel L A M Kuypers; Stefan Böhringer; Janneke Dekker; Ruben S G M Witlox; Stuart B Hooper; Arjan B Te Pas
Journal:  Front Pediatr       Date:  2021-12-03       Impact factor: 3.418

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.